AVI BioPharma (AVII) to Present Data for Duchenne Muscular Dystrophy Therapy at TREAT-NMD/NIH Conference
Tweet Send to a Friend
AVI BioPharma, Inc. (NASDAQ: AVII) today announced presentations on the company's exon skipping therapy for Duchenne muscular dystrophy at the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
